Epidemiology and clinical features in patients with COVID-19 in Mexican Southeast: A retrospective analysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12620001265965

Acronym

None

Enrollment

1000

Registered

2020-11-25

Start date

2020-03-30

Completion date

2020-09-15

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

SARS-CoV-2 is fastly transmittable between humans and has affected approximately 17.6 million people worldwide. As of July 2020, the World Health Organization (WHO) reported around 425000 confirmed cases in Mexico. In Tabasco, a state located in southeast Mexico reported 21300 cases for COVID-19. It is noteworthy that "Dr. Juan Graham Casasús" Hospital is the most important for the COVID-19 attention in Tabasco. Hence, the present study aims to determine the sociodemographic, clinical, imaging features, and biochemical levels of adult survivors and non-survivors of COVID-19 infection treated at the "Dr. Juan Graham Casasus" Hospital in Tabasco, Mexico. So the retrospective analysis of the epidemiology and clinical features in patients with COVID-19 contributes to the scientific actualization of clinical work carried out during the pandemic.

Interventions

Coronavirus disease 2019 (COVID-19) caused by the virus SARS-CoV-2 defines as a pandemic respiratory infection that causes fever, cough, dyspnea, and pulmonary interstitial damage. Unfortunately, SARS-CoV-2 is fastly transmittable between humans and has affected approximately 17.6 million people worldwide. As of July 2020, the World Health Organization (WHO) reported around 425000 confirmed cases in Mexico. In Tabasco, a state of the southeast of Mexico has reported 21300 cases for COVID-19. The "Dr. Juan Graham Casasús" Hospital received nearly 3000 patients during the pick of the pandemic. Therefore, this proposal is based on the outcomes of hospitalized patients by COVID-19 in Tabasco. This retrospective study will evaluate the medical records of patients diagnosed with COVID-19 in a third-level hospital in Tabasco, from admission until discharge/death. We will collect sociodemographic, comorbidities, and clinical symptoms at admission, then pharmacological treatment, and laboratory data.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

All survivors and non-survivors patients diagnosed with COVID-19 in a third level hospital in Tabasco, Mexico.

Exclusion criteria

Patients hospitalized by other clinical conditions. Patients without vital signs at respiratory triage. Patients hospitalized with incomplete clinical records. Pregnancy women. Age <18 years.

Outcome results